Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 45.45% vs -15.38% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -21.23% vs -17.78% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -9.09% vs -1.46% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of AC Immune SA With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 45.45% vs -15.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.00% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -21.23% vs -17.78% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.98% vs -34.76% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -9.09% vs -1.46% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -0.88% vs -20.86% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






